tradingkey.logo

Mainz Biomed NV

MYNZ
1.170USD
+0.020+1.74%
Close 12/24, 13:00ETQuotes delayed by 15 min
4.79MMarket Cap
LossP/E TTM
You can access the annual and quarterly cash flow statements of Mainz Biomed NV to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024H2
FY2024H1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022H2
FY2022H1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---8.95M
---8.14M
---4.66M
---6.51M
---5.12M
---5.66M
---8.31M
---6.46M
Net income from continuing operations
---10.63M
---11.02M
---5.18M
---6.30M
---8.25M
---6.56M
---13.78M
---12.60M
Operating gains losses
--520.09K
--496.95K
--204.47K
--203.57K
--171.02K
--287.35K
--317.43K
--62.37K
Other non-cash items
--1.74M
--692.74K
---730.40K
--182.81K
--4.75K
--92.30K
---14.38K
--41.17K
Change in working capital
---609.20K
--660.95K
--235.08K
---1.68M
--1.78M
---397.55K
--1.03M
--359.94K
-Change in receivables
--129.23K
---64.95K
--101.23K
---144.59K
--31.24K
--27.66K
---163.86K
---47.37K
-Change in inventory
--21.54K
--8.27K
---158.13K
---133.69K
---121.05K
---87.31K
---134.11K
---38.27K
-Change in prepaid expenses
---441.89K
--450.66K
---132.18K
---479.55K
--318.44K
--53.58K
---385.87K
--332.08K
-Change in payables and accrued expense
---200.55K
--285.16K
--484.67K
---925.95K
--1.55M
---390.17K
--1.71M
--113.50K
-Change in other current liabilities
---117.53K
---18.20K
---60.52K
--1.33K
---21.00
---1.31K
----
----
Cash from non-recurring investing activities
Cash from operating activities
---8.95M
---8.14M
---4.66M
---6.51M
---5.12M
---5.66M
---8.31M
---6.46M
Investing cash flow
Net cash from continuing investing activities
---189.06K
--420.66K
--261.81K
--112.48K
--123.63K
--1.40M
--406.04K
--252.45K
Capital expenditures
----
--420.66K
--261.81K
--112.48K
--123.63K
--1.40M
--406.04K
--252.45K
Net cash flow from disposal of fixed assets
---39.06K
--120.66K
--161.81K
--12.48K
--123.63K
--900.93K
--406.04K
--252.45K
Net cash flow from intangible asset transactions
---150.00K
--300.00K
--100.00K
--100.00K
--0.00
--500.00K
----
----
Net cash flow from business transactions
--32.78K
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
--221.84K
---420.66K
---261.81K
---112.48K
---123.63K
---1.40M
---406.04K
---252.45K
Financing cash flow
Cash flow from continuous financing activities
--14.05M
--2.55M
--3.47M
--4.57M
--5.42M
--773.48K
---148.23K
--24.09M
Net cash flow from debt Issuance/repayment
--798.85K
--2.04M
---1.03M
--5.50M
--4.39M
---91.28K
---148.23K
---156.74K
Net cash flow from common stock issuance/repurchase
--13.25M
--515.26K
--4.50M
---1.55K
--611.36K
--1.28M
----
--23.87M
Proceeds from issuance of warrants
----
----
----
--0.00
--0.00
--0.00
--0.00
--382.50K
Net cash flow from other financing activities
----
----
--1.12K
---934.87K
--418.63K
---418.63K
---1.00
----
Net cash from non-recurrent financing activities
Net cash from financing activities
--14.05M
--2.55M
--3.47M
--4.57M
--5.42M
--773.48K
---148.23K
--24.09M
Net cash flow
Beginning cash balance
--977.76K
--7.07M
--9.32M
--10.91M
--10.86M
--17.14M
--26.01M
--8.73M
Current period cash flow changes
--5.26M
---6.09M
---2.25M
---1.59M
--52.88K
---6.28M
---8.86M
--17.28M
Effect of exchange rate changes
---66.97K
---79.08K
---798.27K
--458.93K
---123.78K
--3.26K
--2.12K
---103.23K
Ending cash balance
--6.24M
--977.76K
--7.07M
--9.32M
--10.91M
--10.86M
--17.14M
--26.01M
Free cash flow
---8.95M
---8.57M
---4.92M
---6.62M
---5.24M
---7.06M
---8.72M
---6.71M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--

FAQs

What is the cash flow statement?

This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.
KeyAI